Expert panel report on a study of Splenda in male rats.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Regulatory toxicology and pharmacology : RTP

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.yrtph.2009.06.013PMID 19567260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of Cytochrome P450 Protein Expression along the Entire Length of the Intestine of Male and Female Rats

  2008cited by this paper
• OECD GUIDELINES FOR THE TESTING OF CHEMICALS

  2008cited by this paper
• Splenda Alters Gut Microflora and Increases Intestinal P-Glycoprotein and Cytochrome P-450 in Male Rats

  2008influential reference
• Small Changes in Dietary Sugar and Physical Activity as an Approach to Preventing Excessive Weight Gain: The America on the Move Family Study

  2007cited by this paper
• A review of the effectiveness of aspartame in helping with weight control

  2006cited by this paper
• Dietary carbohydrate source influences molecular fingerprints of the rat faecal microbiota

  2006cited by this paper
• Position of the American Dietetic Association: use of nutritive and nonnutritive sweeteners.

  2004cited by this paper
• Role of P-Glycoprotein in Pharmacokinetics

  2003cited by this paper
• Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes.

  2003cited by this paper
• Opinion of the Scientific Committee on Food

  2001cited by this paper
• A combined chronic toxicity/carcinogenicity study of sucralose in Sprague-Dawley rats.

  2000cited by this paper
• Repeated dose study of sucralose tolerance in human subjects.

  2000cited by this paper
• The metabolic fate of sucralose in rats.

  2000cited by this paper
• The pharmacokinetics and metabolism of sucralose in the mouse.

  2000cited by this paper
• Influence of dietary components on the gastrointestinal metabolism and transport of drugs.

  2000influential reference
• Acute and subchronic toxicity of sucralose.

  2000cited by this paper
• The pharmacokinetics and metabolism of sucralose in the dog.

  2000cited by this paper
• Sucralose metabolism and pharmacokinetics in man.

  2000influential reference
• St John's Wort induces intestinal P‐glycoprotein/MDR1 and intestinal and hepatic CYP3A4

  2000cited by this paper
• The pharmacokinetics and metabolism of sucralose in the rabbit.

  2000cited by this paper
• A carcinogenicity study of sucralose in the CD-1 mouse.

  2000cited by this paper
• Sucralose--an overview of the toxicity data.

  2000cited by this paper
• The effect of sucrose or starch‐based diet on short‐chain fatty acids and faecal microflora in rats

  1999cited by this paper
• Position of the American Dietetic Association: use of nutritive and nonnutritive sweeteners.

  1998cited by this paper
• No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.

  1998cited by this paper
• Predictive food microbiology Gedanken experiment : why do microbial growth data require a transformation ?

  1998cited by this paper
• The effect of aspartame as part of a multidisciplinary weight-control program on short- and long-term control of body weight.

  1997cited by this paper
• Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.

  1996cited by this paper
• Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases.

  1995cited by this paper
• Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.

  1994influential reference
• Alternative sweeteners (2nd edn): edited by Lyn O'Brien Nabors and Robert C. Gelardi, Marcel Dekker, 1991, $145.00 (vii + 461 pages) ISBN 0 8247 8475 8

  1993cited by this paper
• Amounts of viable anaerobes, methanogens, and bacterial fermentation products in feces of rats fed high-fiber or fiber-free diets

  1993cited by this paper
• Sucralose : features and benefits

  1993cited by this paper
• Rats fed high starch diets have lower colonic proliferation and fecal bile acids than high sucrose-fed controls.

  1993cited by this paper
• Evaluation of data transformations used with the square root and schoolfield models for predicting bacterial growth rate

  1992cited by this paper
• Effects of intense sweeteners on hunger, food intake, and body weight: a review.

  1991cited by this paper
• Stability of sucralose in baked goods

  1990cited by this paper
• Physicochemical Properties of the Sweetener Sucralose

  1989influential reference
• Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.

  1989cited by this paper
• Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation

  1989cited by this paper
• Influence of starches of low digestibility on the rat caecal microflora

  1988cited by this paper
• Toxicological evaluation of certain food additives and contaminants

  1987cited by this paper
• The pharmacokinetics of Norpace.

  1975cited by this paper
• Who Food Additives Series

  1973cited by this paper
• Enzyme induction.

  1972cited by this paper
• On the logarithmid transformation of intestinal bacterial counts.

  1970cited by this paper
• [What is pharmacokinetics?].

  1967cited by this paper

• Sweet surfactants I: Fatty acid esters of sucralose.

  2021cites this paper
• Low Calorie Sweeteners Differ in Their Physiological Effects in Humans

  2019cites this paper
• Xenobiotics and the Gut Microbiome in Health and Disease

  2019cites this paper
• Review of the scientific evidence and technical opinion on noncaloric sweetener consumption in gastrointestinal diseases.

  2019cites this paper
• Assessing the in vivo data on low/no-calorie sweeteners and the gut microbiota.

  2019cites this paper
• Review of the scientific evidence and technical opinion on noncaloric sweetener consumption in gastrointestinal diseases

  2019cites this paper
• Non-nutritive Sweeteners: Implications for Consumption in Athletic Populations

  2019cites this paper
• Non-nutritive Sweeteners and Glycaemic Control

  2019cites this paper
• The impact of three commercial sweeteners on cytokine expression by mononuclears impelled by colon carcinoma cells

  2019influential citation
• A Personalised Dietary Approach—A Way Forward to Manage Nutrient Deficiency, Effects of the Western Diet, and Food Intolerances in Inflammatory Bowel Disease

  2019cites this paper
• Revisited: Assessing the in vivo data on low/no-calorie sweeteners and the gut microbiota.

  2019cites this paper
• Toxic emissions resulting from sucralose added to electronic cigarette liquids

  2019cites this paper
• Oral and Post‐Oral Actions of Low‐Calorie Sweeteners: A Tale of Contradictions and Controversies

  2018cites this paper
• Key Genotypes and the Response to Nutrient Supplementation in Crohn’s Disease

  2018cites this paper
• Biochemical Changes in Fatty Acids, Hydrocarbons and Sterols as well as Total Lipids of Albino Rats Ingested some Synthetic Colourants and Flavourants as Food Additives

  2017cites this paper
• Statement on the validity of the conclusions of a mouse carcinogenicity study on sucralose (E 955) performed by the Ramazzini Institute

  2017cites this paper
• Gut Microbiome Response to Sucralose and Its Potential Role in Inducing Liver Inflammation in Mice

  2017cites this paper
• Critical review of the current literature on the safety of sucralose.

  2017cites this paper
• Sucralose administered in feed, beginning prenatally through lifespan, induces hematopoietic neoplasias in male swiss mice

  2016cites this paper
• Sucralose administered in feed, beginning prenatally through lifespan, induces hematopoietic neoplasias in male swiss mice

  2016cites this paper
• Do low-calorie sweeteners promote weight gain in rodents?

  2016cites this paper
• Extemporaneous Formulations of Metformin for Pediatric Endocrinology: Physicochemical Integrity, Cytotoxicity of Sweeteners, and Quantitation of Plasma Levels.

  2015cites this paper
• Non-caloric artificial sweeteners and the microbiome: findings and challenges

  2015cites this paper
• Obsessive-compulsive disorder and gut microbiota dysregulation.

  2014cites this paper
• Adding Molecules to Food, Pros and Cons: A Review on Synthetic and Natural Food Additives.

  2014cites this paper
• Xylitol improves pancreatic islets morphology to ameliorate type 2 diabetes in rats: a dose response study.

  2014cites this paper
• Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.

  2014cites this paper
• Studies on the possible mechanisms behind the anti-diabetic effects of Xylitol.

  2013cites this paper
• Sucralose, A Synthetic Organochlorine Sweetener: Overview of Biological Issues

  2013cites this paper
• Non-nutritive sweeteners: review and update.

  2013cites this paper
• Sucralose revisited: rebuttal of two papers about Splenda safety.

  2012influential citation
• Response to the Letter to the Editor by S. Schiffman and M. Abou-Donia: Additional information to clarify the evidence of sucralose safety

  2012cites this paper
• Effects of Xylitol on Blood Glucose, Glucose Tolerance, Serum Insulin and Lipid Profile in a Type 2 Diabetes Model of Rats

  2012cites this paper
• Presence, fate and effects of the intense sweetener sucralose in the aquatic environment.

  2012cites this paper
• Cob(I)alamin reacts with sucralose to afford an alkylcobalamin: relevance to in vivo cobalamin and sucralose interaction.

  2011cites this paper
• An overview of the safety of sucralose.

  2009cites this paper